SCHEMBL2275466

SCHEMBL2275466

COc1cccc(/C=C/c2ccc(C(=O)OC(C)(C)C)c(NC(=O)c3cccc(C)c3C)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NR1H4 Q96RI1 2/20 0.41
RELA Q04206 1/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NFE2L2 Q16236 1/20 0.38
CYP19A1 P11511 1/20 0.38
NQO2 P16083 1/20 0.38
KDM4E B2RXH2 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
SNCA P37840 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275469 1.00 ALDH1A1 (0.43) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL2273551 0.87 ALDH1A1 (0.47) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL2273540 0.87 ALDH1A1 (0.47) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL12394963 0.86 ALDH1A1 (0.49) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL2271183 0.83 NFE2L2 (0.51) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL2271176 0.83 NFE2L2 (0.51) ALDH1A1RAB9ANPC1MEN1KMT2A
SCHEMBL4218410 0.77 NFE2L2 (0.53) ALDH1A1MEN1KMT2ANR1H4RELA
SCHEMBL4218416 0.77 NFE2L2 (0.53) ALDH1A1MEN1KMT2ANR1H4RELA
SCHEMBL2275308 0.76 CYP19A1 (0.53) NR1H4RELAABCG2MAOAMAOB
SCHEMBL2275299 0.76 CYP19A1 (0.53) NR1H4RELAABCG2MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 ALDH1A1 645/4885RAB9A 2238/4885NPC1 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.